Indian Pharma Market registers 8 percent surge to Rs 17,937 Crore in January 2024: IQVIA Farhat Nasim19 Feb 2024 7:19 PM ISTNew Delhi: In an impressive kickoff to 2024, the Indian pharmaceutical market surged by 8%, reaching a substantial Rs 17,937 crore in January, as per...
Indian pharmaceutical market registers 9 percent growth in September: IQVIA Report Susmita Roy3 Nov 2023 5:43 PM ISTNew Delhi: The Indian Pharmaceutical Market (IPM) has witnessed a spike of nine percent in September 2023, according to International Quality and...
Indian Pharma Market registers 11 percent growth in April: IQVIA Farhat Nasim24 May 2023 11:51 AM ISTNew Delhi: The Indian Pharmaceutical Market (IPM) has reported double-digit growth of 11 percent for the month of April 2023, according to IQVIA.On a...
IQVIA gets CDSCO panel Nod To Study ABX464 Dr. Divya Colin8 May 2023 5:30 PM ISTNew Delhi: The leading global contract research organization, IQVIA has got the green signal from the Subject Expert Committee(SEC) functional under...
IPM grew 19 percent in March, brands like Calpol, Augmentin observed highest growth: IQVIA Farhat Nasim12 April 2023 6:09 PM ISTNew Delhi: The Indian pharmaceutical market reported double-digit growth of 19 percent in the month of March 2023, according to IQVIA. The...
Indian pharma market reflects growth of 7 percent in year 2022 Roshni Dhar9 March 2023 6:45 PM ISTThe Indian Pharmaceutical Market (IPM) has reflected growth of 7 percent in the year 2022 with overall IPM market size at Rs 1,93,838 crore Moving...
Health Bulletin 9/March/2023 Roshni Dhar9 March 2023 4:11 PM ISTHere are the top health stories for the day:900 NEET SS seats still vacant: Doctors demand another Mop-Up RoundPointing out that more than 900...
IQVIA gets CDSCO panel okay to reopen trial recruitment in the country for Evobrutinib Dr. Divya Colin26 Oct 2022 1:30 PM ISTNew Delhi: Approving IQVIA proposal to amend Phase III Clinical Trail protocol of Bruton's tyrosine kinase (BTK) inhibitor Evobrutinib, the Subject...
IQVIA Gets CDSCO Panel Nod To Study AVT06 biosimilar candidate to Eylea Dr. Divya Colin9 Oct 2022 1:40 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has granted permission to the...
Dr Reddy's Labs, IQVIA ink pact for CRM solution for India field force Ruchika Sharma29 Sept 2022 11:15 AM ISTOCE is IQVIA's CRM Application Suite that enables life sciences clients to digitally transform their sales and marketing operations.
Alembic Pharmaceuticals receives USFDA nod for Lacosamide Tablets MD Bureau23 March 2022 6:51 PM ISTLacosamide Tablets, 50 mg, 100 mg, 150 mg, and 200 mg, have an estimated market size of US dollar 1.67 billion for twelve months ending December 2021...
Glenmark Pharmaceuticals receives ANDA approval for Lacosamide Tablets MD Bureau21 March 2022 3:48 PM ISTAccording to IQVIA sales data for the 12 month period ending January 2022, the Vimpat Tablets, 50 mg, 100 mg, 150 mg and 200 mg market3 achieved...
